Catalyst Wire Dossier Catalyst Wire Dossier

Recombinant Human Mannose-Binding Lectin (MBL)

mannose-binding lectin · Enzon Pharmaceuticals, Inc.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Recombinant Human Mannose-Binding Lectin (MBL), covering 2012-06-20 to 2012-06-20. Get the full timeline:

Most recent: Clinical Trial Update: Recombinant Human Mannose-Binding Lectin (MBL) in Treating Young Patients With MBL Deficiency and Fever and Neutropenia [Phase 1]

See pricing